The University of Vienna experience in heart transplantation.
Since the University of Vienna Cardiac Transplant Program began in 1984, 892 heart transplant procedures have been performed through the end of 2001. One- and five-year survival has increased steadily over time to 80% and 75%, respectively, in the most recent cohort. Ten-year survival is 55%. Over the past 10 years our program has seen dramatic changes in patient selection, accepting now patients with more risk factors (age, diabetes, elevated pulmonary resistance,..). Developments in immunosuppression have decreased the incidence of infection, rejection and graft arteriosclerosis continuously. Our program continues to pursue novel strategies to improve the survival and quality of life of our heart transplant patients.
Zuckermann
Andreas
A
Department of Cardio-Thoracic Surgery, University of Vienna, Austria.
Bohdjalian
Arthur
A
Deviatko
Elena
E
Dunkler
Daniela
D
Rödler
Suzanne
S
Ehrlich
Marek
M
Wieselthaler
Georg
G
Pacher
Richard
R
Bunzel
Brigitte
B
Wollenek
Gregor
G
Laczkovics
Axel
A
Laufer
Günther
G
Wolner
Ernst
E
Grimm
Michael
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D001317:Austria; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D006084:Graft Rejection / Q000517:prevention & control; D016027:Heart Transplantation / Q000401:mortality / Q000706:statistics & numerical data*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D008875:Middle Aged; D018579:Patient Selection; D011183:Postoperative Complications / Q000145:classification / Q000517:prevention & control; D012307:Risk Factors; D016019:Survival Analysis; D014019:Tissue Donors / Q000600:supply & distribution
D007166:Immunosuppressive Agents